Transforming Biopharma Operations with Advanced Generative AI
Daliscia harnesses the power of generative AI to streamline operations, ensure compliance, reduce deviations, and accelerate time-to-market in the pharmaceutical industry.

How We Transform Biopharma Operations
Our AI solutions are designed to support pharmaceutical operational challenges across the value chain while working within your quality framework.

AI-Generated Lab Protocols
Accelerate R&D with AI agents that search scientific literature and generate optimized, GMP-compliant protocols. Reduce protocol development time by up to 30% while ensuring consistent quality and regulatory compliance.

Batch Record Analysis
Extract critical quality attributes from batch records with 99% accuracy. Our GenAI solution reduces review time by 40%, minimizes human error, and ensures data integrity for regulatory submissions. Fully compliant with 21 CFR Part 11 requirements.

Smart Deviation Management
Reduce deviations by 30-40% through improved prevention and automation. Our solution identifies similar historical deviations, accelerates root cause analysis, suggests effective CAPAs, and ensures consistent documentation—all while maintaining strict GMP compliance.

Shop Floor Efficiency
Empower manufacturing supervisors with our GenAI assistant that reduces administrative workload by 40-50%. Free supervisors from manual reporting and equipment troubleshooting so they can focus on team leadership and process improvement.

Document Digitization & Knowledge Management
Transform legacy documentation into searchable, AI-powered knowledge bases. Reduce document processing time by 45% and decrease time spent searching for information by 25%, all while maintaining GMP compliance with audit trails and access controls.

Tailored Biopharma AI Integration
Custom AI solutions designed for your unique regulatory requirements and workflow challenges.
Ready to Transform Your R&D?
Join leading pharma companies that have accelerated their drug discovery pipeline by up to 60% using our AI solutions.